BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 29695348)

  • 1. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial.
    Schäfer R; Strnad V; Polgár C; Uter W; Hildebrandt G; Ott OJ; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Gall C; Polat B;
    Lancet Oncol; 2018 Jun; 19(6):834-844. PubMed ID: 29695348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial.
    Strnad V; Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Łyczek J; Guinot JL; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Fietkau R; Schlamann A; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Dunst J; Gall C; Uter W;
    Lancet Oncol; 2023 Mar; 24(3):262-272. PubMed ID: 36738756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial.
    Strnad V; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Gutierrez Miguelez C; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Hindemith M; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C;
    Lancet; 2016 Jan; 387(10015):229-38. PubMed ID: 26494415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
    Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
    Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
    Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF; Winter KA; Paik S; Kuerer HM; Vallow LA; Pierce LJ; Mamounas EP; McCormick B; Costantino JP; Bear HD; Germain I; Gustafson G; Grossheim L; Petersen IA; Hudes RS; Curran WJ; Bryant JL; Wolmark N
    Lancet; 2019 Dec; 394(10215):2155-2164. PubMed ID: 31813636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial.
    Whelan TJ; Julian JA; Berrang TS; Kim DH; Germain I; Nichol AM; Akra M; Lavertu S; Germain F; Fyles A; Trotter T; Perera FE; Balkwill S; Chafe S; McGowan T; Muanza T; Beckham WA; Chua BH; Gu CS; Levine MN; Olivotto IA;
    Lancet; 2019 Dec; 394(10215):2165-2172. PubMed ID: 31813635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
    Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient compliance.
    Ott OJ; Strnad V; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Łyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Wendt TG; Fietkau R; Kortmann RD; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Malzer M; Uter W; Polgár C;
    Radiother Oncol; 2016 Jul; 120(1):119-23. PubMed ID: 27422584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial.
    Velikova G; Williams LJ; Willis S; Dixon JM; Loncaster J; Hatton M; Clarke J; Kunkler IH; Russell NS;
    Lancet Oncol; 2018 Nov; 19(11):1516-1529. PubMed ID: 30337220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
    Bartelink H; Maingon P; Poortmans P; Weltens C; Fourquet A; Jager J; Schinagl D; Oei B; Rodenhuis C; Horiot JC; Struikmans H; Van Limbergen E; Kirova Y; Elkhuizen P; Bongartz R; Miralbell R; Morgan D; Dubois JB; Remouchamps V; Mirimanoff RO; Collette S; Collette L;
    Lancet Oncol; 2015 Jan; 16(1):47-56. PubMed ID: 25500422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
    Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
    Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
    Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation.
    Cambeiro M; Martinez-Regueira F; Rodriguez-Spiteri N; Olartecoechea B; Insausti LP; Elizalde A; Gastearena MI; Gallego JS; Santisteban M; Aramendía JM; Aristu JJ; Moreno LA; Moreno-Jiménez M; Valtueña G; Martínez-Monge R
    Brachytherapy; 2016; 15(4):485-494. PubMed ID: 27129410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.
    Strnad V; Major T; Polgar C; Lotter M; Guinot JL; Gutierrez-Miguelez C; Galalae R; Van Limbergen E; Guix B; Niehoff P; Lössl K; Hannoun-Levi JM
    Radiother Oncol; 2018 Sep; 128(3):411-420. PubMed ID: 29691075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.
    Kunkler IH; Williams LJ; Jack WJ; Cameron DA; Dixon JM;
    Lancet Oncol; 2015 Mar; 16(3):266-73. PubMed ID: 25637340
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hannoun-Levi JM; Chamorey E; Boulahssass R; Polgar C; Strnad V;
    Clin Transl Radiat Oncol; 2021 Jul; 29():1-8. PubMed ID: 33997321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer.
    Garsa AA; Ferraro DJ; DeWees TA; Deshields TL; Margenthaler JA; Cyr AE; Naughton M; Aft R; Gillanders WE; Eberlein T; Matesa MA; Ochoa LL; Zoberi I
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1043-50. PubMed ID: 24161428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated partial breast irradiation for elderly women with early breast cancer: A compromise between whole breast irradiation and omission of radiotherapy.
    Sumodhee S; Levy J; Chamorey E; Lam Cham Kee D; Chand ME; Gautier M; Peyrottes I; Barranger E; Hannoun-Levi JM
    Brachytherapy; 2017; 16(5):929-934. PubMed ID: 28697858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
    Gabani P; Cyr AE; Zoberi JE; Ochoa LL; Matesa MA; Thomas MA; Garcia J; Margenthaler JA; Naughton MJ; Ma C; Sanati S; Zoberi I
    Brachytherapy; 2018; 17(1):171-180. PubMed ID: 29089275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.